Press ReleasesGlass Pharms Announces Partners In UK Cultivation Facility: KUBO...

Glass Pharms Announces Partners In UK Cultivation Facility: KUBO To Build State-Of-The-Art Greenhouse 


HAVING secured up to £26.7m of funding from a FTSE-250 listed investment fund, Glass Pharms, the UK-based medical cannabis cultivation company, are delighted to announce a team of best-of-breed partners to complete their cultivation facility.

KUBO have been selected to deliver a state-of-the-art greenhouse for the Glass Pharms facility to ensure sophisticated control of climatic conditions and low energy consumption using its patented Ultra-Clima® system. The carbon negative facility will be powered entirely by renewable energy generated from food waste fed into an anaerobic digestion (AD) plant. Waste hot water from the AD plant will also be used for both heating and cooling.

The greenhouse will harvest and recycle rainwater and will represent a new benchmark for sustainable enclosed agriculture in the UK. Askam Civil Engineering, with specific sector expertise, will be providing the required civils and headhouse fitout for the facility.

CGI of the new facility

Glass Pharms have the first UK commercial licence granted by the Home Office to supply High-THC cannabis flower to lawful pharmaceutical companies, granted in 2021. Earlier this year it announced Richard Lewis, one of the UK’s most experienced glasshouse growers, as its managing director and will shortly announce its plant specific expert.

‘We will underpin a secure supply chain of affordable medical cannabis to UK patients without them having to compromise on freshness or quality, whilst at the same time making a real contribution towards the UK’s Net Zero targets.’ said Duckenfield.

UK Medical Cannabis Market

Medical Cannabis was legalised in the UK in November 2018 with an amendment of The Misuse of Drugs Regulations 2001, allowing the prescription of cannabis-based products for medicinal use (CBPMs) to UK patients. 

About Glass Pharms

Glass Pharms is a UK-based medical cannabis cultivator focused on the UK medical cannabis market. It combines the latest agricultural and scientific methods to cultivate top quality flowers within pharmaceutical tolerances with the objective of facilitating affordable high-quality CBPMs.

About KUBO

KUBO is a world leader in the design and construction of high-tech greenhouse facilities, with a 77-year track record in the Netherlands, and projects worldwide. It is the company’s mission to provide the complete solutions that will allow the next generation of entrepreneurs to grow more using fewer resources – including energy, water, and CO2 – whilst maintaining the highest level of product safety.

More information on the company can be found on its website

Latest news

Tilray’s Medical Cannabis Product Now Available And Reimbursed Under Ireland’s Medical Cannabis Access Program

PRESS RELEASE TILRAY Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and...

Grow Group, Kanabo, MGC Pharma & Celadon Pharma All Report Growing Revenues, But Continue To Post Losses

AMID the economic chaos that dominated the headlines over the past week, nearly half-a-dozen UK-based or UK-listed cannabis companies...

MGC Pharma Announces Appointment Of UK Advisor And New COO/Deputy CEO

MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') a European based bio-pharma company specialising in the production and development...

Sanity Group’s Record Funding Round Led By BAT Could Bring More Big-Tobacco Capital To Cannabis, But Concerns Remain Over Conflicts Of Interest

LAST week Berlin-based cannabis operator Sanity Group closed Europe’s largest ever cannabis investment round worth €37.6m, bringing its total...

European Cannabis Stocks Review: £22m Wiped From LSE-Listed Cannabis Stocks Amid Market Chaos

FOLLOWING a few weeks of relative positivity for many of the stocks listed on the London Stock Exchange (LSE),...

German SPD Representatives Confident A Solution To International Legal Hurdles Will Be Found

EARLIER this month news broke that recent analysis conducted by the Bundestag's scientific service suggested the creation of a...

Must read

You might also likeRELATED
Recommended to you